1. Home
  2. FMAO vs ALT Comparison

FMAO vs ALT Comparison

Compare FMAO & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMAO
  • ALT
  • Stock Information
  • Founded
  • FMAO 1897
  • ALT 1997
  • Country
  • FMAO United States
  • ALT United States
  • Employees
  • FMAO N/A
  • ALT N/A
  • Industry
  • FMAO Savings Institutions
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMAO Finance
  • ALT Health Care
  • Exchange
  • FMAO Nasdaq
  • ALT Nasdaq
  • Market Cap
  • FMAO 356.9M
  • ALT 292.0M
  • IPO Year
  • FMAO N/A
  • ALT N/A
  • Fundamental
  • Price
  • FMAO $26.13
  • ALT $3.83
  • Analyst Decision
  • FMAO
  • ALT Strong Buy
  • Analyst Count
  • FMAO 0
  • ALT 6
  • Target Price
  • FMAO N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • FMAO 21.8K
  • ALT 3.0M
  • Earning Date
  • FMAO 10-29-2025
  • ALT 08-12-2025
  • Dividend Yield
  • FMAO 3.34%
  • ALT N/A
  • EPS Growth
  • FMAO 38.39
  • ALT N/A
  • EPS
  • FMAO 2.16
  • ALT N/A
  • Revenue
  • FMAO $108,632,000.00
  • ALT $20,000.00
  • Revenue This Year
  • FMAO $1.60
  • ALT N/A
  • Revenue Next Year
  • FMAO $13.77
  • ALT $761,880.20
  • P/E Ratio
  • FMAO $12.26
  • ALT N/A
  • Revenue Growth
  • FMAO 13.86
  • ALT N/A
  • 52 Week Low
  • FMAO $20.88
  • ALT $2.90
  • 52 Week High
  • FMAO $34.15
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • FMAO 58.09
  • ALT 51.79
  • Support Level
  • FMAO $24.60
  • ALT $3.35
  • Resistance Level
  • FMAO $27.01
  • ALT $3.66
  • Average True Range (ATR)
  • FMAO 0.81
  • ALT 0.19
  • MACD
  • FMAO 0.23
  • ALT 0.07
  • Stochastic Oscillator
  • FMAO 89.44
  • ALT 86.18

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: